(Q86423891)
Statements
Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study): 1-year results (English)
Ingrid U Scott
Léssia P Cintra
Daniela Calucci
scientific article published on 01 June 2013